The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease

Journal of the American Society of Nephrology

Volumn 14, Issue 6, 2003, Pages 1568-1577

  Muntner, Paul ^a,b   Coresh, Josef ^c,d,e   Powe, Neil R ^c,d,e   Klag, Michael J ^a,c,e  

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COST; DIABETES MELLITUS; HEART INFARCTION; HUMAN; INCIDENCE; KIDNEY FAILURE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; STROKE; SURVIVAL; UNITED STATES;

EID: 0038512408     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000067420.83632.C1     Document Type: Article

References (22)

1. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, Marks JS: Diabetes trends in the U.S.: 1990-1998. Diabetes Care 23: 1278-1283, 2000
2. Harris MI: Diabetes in America. National Diabetes Data Group. NIH publication number 95-1468, 1-13. Bethesda MD, National Instititutes of Health, 1995
3. Goldberg R, Gore J, Alpert J, Dalen J: Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981): The Worchester Heart Attack Study. JAMA 255: 2774-2779, 1986
4. Feinleib M: The magnitude and nature of the decrease in coronary heart disease mortality rate. Am J Cardiol 54: 2c-6c, 1984
5. Muntner P, Garrett E, Klag MJ, Coresh J: Trends in stroke prevalence between 1973 and 1991 in the US population 25 to 74 years of age. Stroke 33: 1209-1213, 2002
6. Brancati FL, Whelton PK, Randall B, Neaton J, Stamler J, Klag MJ: Risk of end-stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT. JAMA 278: 2069-2074, 1997
7. Perneger TV, Brancati FL, Whelton PK, Klag MJ: End-stage renal disease attributable to diabetes mellitus. Ann Intern Med 121: 912-918, 1994
8. Perry H, Miller J, Fomoff J, Baty J, Sambhi M, Rutan G, Moskowitz D, Carmody S: Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 25: 587-594, 1995
9. Furth S, Hermann J, Powe N: Cardiovascular risk factors, and comorbidity, and survival outcomes in black and white dialysis patients. Semin Dial 11: 102-105, 1998
10. United States Renal Data System (USRDS). USRDS 1999 Annual Data Report. The National Institutes of Health. Bethesda MD, National Institutes of Diabetes and Digestive and Kidney Diseases, 1999
11. United States Renal Data System (USRDS). USRDS 2000 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda MD, National Instistutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2000
12. Xue JL, Ma JZ, Louis TA, Collins AJ: Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 12: 2753-2758, 2001
13. Port F: The End-stage renal disease program: Trends over the past 18 years. Am J Kidney Dis 20: 3-7, 1992
14. McDowell A, Engle A, Massey JT, Maurer K: Plan and operation of the Second National Health and Nutrition Examination Survey 1976-1980. Vital Health Statistics 15: 1-144, 1981
15. National Center for Health Statistics: Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994, US Department of Health and Human Services publication 94-1308 1, 1994
16. US Census Bureau. Current Population Reports. Washington, DC, US Census Bureau, 1991
17. US Census Bureau. Current Population Reports: United States Population Estimates: 1979. p1-1129, 3-35, Washington, DC, US Census Bureau, 1979
18. StataCorp: STATA Statistical Software. Release 6.0. College Station, TX, STATA Corporation, 1999
19. Fried LF, Orchard TJ, Kasiske BL: Effect of lipid reduction on the progression of renal disease: A meta-analysis. Kidney Int 59: 260-269, 2001
20. Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 288: 2421-2431, 2002
21. Walker M, Whincup P, Shaper G, Lennon L, Thomson A: Validation of patient recall of doctor-diagnosed heart attack and stroke: A postal questionnaire and record review comparison. Am J Epidemiol 148: 355-361, 1998
22. Engstad T, Bonaa KH, Viitanen M: Validity of self-reported stroke: The Tromso Study. Stroke 31: 1607, 2000